Mary-Jane Burkett
Director of Finance/CFO at NUVO PHARMACEUTICALS INC.
Profile
Mary-Jane E.
Burkett is currently the Chief Financial Officer & Vice President at Nuvo Pharmaceuticals, Inc. She started this position in 2016.
Prior to her current role, she worked as a Controller at Crescita Therapeutics, Inc. Ms. Burkett completed her undergraduate degree at Richard Ivey School of Business.
Mary-Jane Burkett active positions
Companies | Position | Start |
---|---|---|
NUVO PHARMACEUTICALS INC. | Director of Finance/CFO | 01/09/2016 |
Former positions of Mary-Jane Burkett
Companies | Position | End |
---|---|---|
CRESCITA THERAPEUTICS INC. | Comptroller/Controller/Auditor | - |
Training of Mary-Jane Burkett
Richard Ivey School of Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CRESCITA THERAPEUTICS INC. | Health Technology |
Private companies | 1 |
---|---|
Nuvo Pharmaceuticals, Inc.
Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Mary-Jane Burkett